" So, yes, LATCH is CytoDyn’s first explicit step into testing Leronlimab as a cure in humans, likely a Phase I or I/II trial given its exploratory nature."

The LATCH protocols should have been submitted around 1st week of Jan..

Colorectal cancer Interim will be our 1st data.
Also Alzheimer’s

I can't see GF being interested on Latch.
Maybe some data cross cutting I guess.
Just not full ownership, etc....

Buy we're close to so much...of alot.
Yes sir !!